BridgeMD
New treatment option for Nephrolithiasis
Official title Tract Closure in PCNL
ClinicalTrials.gov ID: NCT07668817
What this study is testing
- What it's testing
- This is a prospective, randomized controlled trial evaluating the effect of a hemostatic agent on tract-related bleeding during percutaneous nephrolithotomy (PCNL). Patients undergoing standardized PCNL will be randomized to receive either application of a hemostatic agent or no agent during tract closure, following uniform balloon occlusion, complete aspiration, and irrigation-free endoscopic assessment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- At least one stone ≥ 1.2cm
- Scheduled to undergo planned PCNL
- Age ≥ 18 years
You likely can't join if
- Unable to provide informed consent
- Pre-existing nephrostomy tube
- Multi access cases
- Stone in calyceal diverticulum/hydrocalyx
- Preoperatively planned overnight admission for any reason
- Infundibular stenosis
See the full eligibility criteria
- At least one stone ≥ 1.2cm
- Scheduled to undergo planned PCNL
- Age ≥ 18 years
- Unable to provide informed consent
- Pre-existing nephrostomy tube
- Multi access cases
- Stone in calyceal diverticulum/hydrocalyx
- Preoperatively planned overnight admission for any reason
- Infundibular stenosis
- Coagulation disorders
- Other significant anatomic abnormalities
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.